Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0000882796-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-02-27 | BCRX | McKee Amy E | Dir | A - Grant | $8.75 | +642 | 42.4K | +2% | +$5,618 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-27 | A | A | 642 | $8.75 | 42,432 | D | — | — | (F1) Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250. |